日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
World / US and Canada

Chinese biopharmaceutical company debuts on Nasdaq

By HENG WEILI in New York (China Daily USA) Updated: 2016-03-18 10:01

Hutchison ChinaMediTech Ltd, a Hong Kong-based biopharmaceutical company, started trading on Thursday on the Nasdaq Stock Market in New York.

Chi-Med, as the company is also known, tradeson Nasdaq under the symbol HCM. Shares closed at $13.40 on Thursday, 10 cents below their initial public offering price, after reaching an intraday high of $14.68.

In the IPO, which priced on Thursday morning, Chi-Med sold 7.5 million American depositary shares, raising $101.25 million. Bank of America, Merrill Lynch and Deutsche Bank Securities were the lead underwriters.

The company, which is majority owned by the multinational conglomerate CK Hutchison Holdings Ltd,calls itself a "globally-focused healthcare group which researches, develops, manufactures and sells pharmaceuticals and health-related consumer products".

Its innovation platform is focused on discovering and developing therapeutics in oncology and autoimmune diseases. The commercial platform manufactures, markets and distributes prescription drugs and consumer health products in China.

More specifically, Chi-Med is a developer of targeted, small molecule kinase (enzyme) inhibitors to treat a range of solid tumors, blood cancers and immune diseases. The company is conducting 20 active clinical trials in various countries, including two late-stage studies with AstraZeneca in the US and Eli Lilly in China, working toward potential new drug applications.

"Today is an important milestone for Chi-Med as we go public in the US market," said Simon To, executive director and chairman, who along with CEO Christian Hoggrang the Nasdaq closing bell on Thursday.

"Our R&D is focused on addressing the shortcomings of many of the currently approved kinase inhibitors, specifically the off-target toxicities that limit drug exposure and efficacy," To said. "We hope our efforts will result in life-saving therapies for the many patients around the world with few or no treatment options."

"We welcome Chi-Med as they continue to advance their rapidly growing pipeline," said Bob McCooey, who is the senior vice-president for listing services at Nasdaq. "As the venue of choice for innovators and visionaries around the globe, we are excited to be the strategic partner that supports revolutionary companies as they take on the world stage."

hengweili@chinadailyusa.com

Trudeau visits Sina Weibo
May gets little gasp as EU extends deadline for sufficient progress in Brexit talks
Ethiopian FM urges strengthened Ethiopia-China ties
Yemen's ex-president Saleh, relatives killed by Houthis
Most Popular
Hot Topics

...
主站蜘蛛池模板: 五月天久久婷婷 | 亚洲免费网址 | 毛片大全免费 | 四虎精品在线观看 | 激情视频网址 | 亚洲精品欧美精品 | 亚洲精品视频在线观看免费 | 亚洲a视频 | 日韩在线观看视频一区二区 | 人人看人人做 | 婷婷伊人综合中文字幕 | 一区精品视频 | www久久久com | 在线视频亚洲 | 黄色com| 日本视频黄色 | 日韩精品久久久久久久 | 久久国产视频一区 | 亚州综合| 亚洲做受高潮无遮挡 | 国产精品福利一区二区 | 亚洲男人在线 | h视频免费在线观看 | 国产欧美在线观看视频 | 久久久成人免费视频 | 一级欧美一级日韩片 | 四虎精品视频 | 欧洲中文字幕 | 久久艹影院 | 久久久.com | 国产精品成人va在线观看 | 九九国产精品视频 | 亚洲综合另类小说 | 麻豆国产在线视频 | 国产黄色免费观看 | 91视频在线免费 | 久久久久久久久久久久国产精品 | 中文字幕日韩一区二区 | 欧美激情视频一区二区 | 国产成人精品一区二区三区视频 | 超碰自拍 |